ArticleOncoimmunology2022
Targeting NKG2A to boost anti-tumor CD8 T-cell responses in human colorectal cancer.
Kathleen Ducoin et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
34 papers cite it
this papercites it
ArticleOncoimmunology2022
Kathleen Ducoin et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.